Skip to main content

CEMTREX INC

For the period ended Dec 31, 2024. Filed Feb 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 14, 2025

CETX$0.62-2.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets as of December 31, 2024 (Unaudited) and September 30, 2024

Condensed Consolidated Balance Sheets

(Unaudited)
December 31,September 30,
20242024
Assets
Current assets
Cash and cash equivalents$4,224,130$3,897,511
Restricted cash1,240,1241,522,881
Trade receivables, net9,202,80211,159,676
Trade receivables, net - related party524,838685,788
Inventory, net11,115,4356,988,529
Contract assets, net1,541,239985,207
Prepaid expenses and other current assets1,195,1281,456,687
Total current assets29,043,69626,696,279
Property and equipment, net9,695,2899,133,578
Right-of-use operating lease assets1,837,7691,933,378
Royalties receivable, net - related party274,756456,611
Goodwill3,708,3473,708,347
Other2,129,5662,187,265
Total Assets$46,689,423$44,115,458
Liabilities & Stockholders’ Equity
Current liabilities
Accounts payable$3,469,117$4,520,173
Sales tax payable9,51573,024
Revolving line of credit4,096,8983,125,011
Current maturities of long-term liabilities6,745,4234,732,377
Operating lease liabilities - short-term845,535832,823
Deposits from customers320,130408,415
Accrued expenses1,628,6181,393,902
Accrued payable on inventory in transit5,149,660640,450
Contract liabilities1,279,1851,254,204
Deferred revenue1,206,0521,297,616
Accrued income taxes163,170314,827
Total current liabilities24,913,30318,592,822
Long-term liabilities
Long-term debt11,893,37113,270,178
Long-term operating lease liabilities1,049,3071,159,204
Other long-term liabilities307,468274,957
Deferred Revenue - long-term560,653658,019
Warrant liabilities9,454,8425,199,436
Total long-term liabilities23,265,64120,561,794
Total liabilities48,178,94439,154,616
Commitments and contingencies--
Stockholders’ equity
Preferred stock , $0.001 par value, 10,000,000 shares authorized,
Series 1, 3,000,000 shares authorized, 2,579,994 shares issued and
2,515,894 shares outstanding as of December 31, 2024 and 2,456,827 shares issued and
2,392,727 shares outstanding as of September 30, 2024 (liquidation value of $10 per share)2,5802,457
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at
December 31, 2024 and September 30, 20245050
Common stock, $0.001 par value, 70,000,000 shares authorized,
1,784,575 shares issued and outstanding at December 31, 2024 and
14,176 shares issued and outstanding at September 30, 20241,78514
Additional paid-in capital95,876,23773,262,536
Accumulated deficit(100,109,753)(71,355,386)
Treasury stock, 64,100 shares of Series 1 Preferred Stock at December 31, 2024,
and September 30, 2024(148,291)(148,291)
Accumulated other comprehensive income2,817,8582,949,297
Total Cemtrex stockholders’ equity(1,559,534)4,710,677
Non-controlling interest70,013250,165
Total liabilities and stockholders’ equity$46,689,423$44,115,458
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.